Information
-
Trademark
-
90801633
-
International Classifications
-
Filing Date
June 29, 2021
3 years ago
-
Transaction Date
July 03, 2024
3 months ago
-
Status Date
March 18, 2024
7 months ago
-
Published for Opposition Date
December 20, 2022
a year ago
-
Location Date
February 14, 2023
a year ago
-
Status Code
606
-
Current Location
INTENT TO USE SECTION
Employee Name
WOLD, BARBARA NIELSEN
-
Attorney Docket Number
271659509124
Attorney Name
Anessa O. Kramer
Law Office Assigned Location Code
M50
-
Owners
Mark Drawing Code
4
Mark Identification
NEOGENOMICS EUROPE
Case File Statements
- GS0051: Pre-packaged medical tests kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of clinical medical reagents and assays for use in disease testing for clinical medical laboratory use
- GS0441: Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory services
- DS0000: "EUROPE"
- GS0101: Pre-packaged medical tests kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes for use in disease testing for clinical medical laboratory use
- GS0421: Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific research purposes; molecular sequencing for scientific research purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells all being for scientific purposes; clinical study and testing of cells for scientific or research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for research purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research and scientific purposes, providing medical research information and interactive scientific research information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; software as a service (SAAS) services featuring software for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis; providing temporary use of cloud-based non-downloadable computer software providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes
Case File Event Statements
-
7/2/2021 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
9/11/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/20/2022 - 2 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/28/2022 - 2 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/28/2022 - 2 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/28/2022 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/13/2022 - 2 years ago
7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
6/13/2022 - 2 years ago
8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
6/13/2022 - 2 years ago
9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
9/27/2022 - 2 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/27/2022 - 2 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/28/2022 - 2 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/16/2022 - a year ago
13 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/30/2022 - a year ago
14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
12/20/2022 - a year ago
15 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
12/20/2022 - a year ago
16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
2/1/2023 - a year ago
19 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
2/1/2023 - a year ago
17 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
2/1/2023 - a year ago
18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
3/18/2024 - 7 months ago
26 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Type: MAB6
-
3/18/2024 - 7 months ago
25 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
-
2/14/2023 - a year ago
20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
8/10/2023 - a year ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
8/10/2023 - a year ago
22 - SOU EXTENSION 1 FILED
Type: EXT1
-
8/10/2023 - a year ago
23 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
8/12/2023 - a year ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA